A 6,9-Imino Ether. -All target compounds (I) show potent activities against erythromycin-susceptible S.pneumoniae comparable to erythromycin A, clarithromycin and azithromycin, Additionally, the new imino ethers exhibit improved activities against erythromycin-resistant S.pneumoniae B1 and AB11 compared with erythromycin A and azithromycin. -(ZHANG, L.; JIAO, B.; YANG, X.; LIU, L.; MA*, S.; J. Antibiot. 64 (2011) 3, 243-247, http://dx.